SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '42A'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	4 / 6	ILE A 29 VAL A 37 ILE A 81 ASP A 165	42A A 402 ( 4.7A) None None None	0.62A	1uwhA-4xrlA: 22.3	1uwhA-4xrlA: 27.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	4 / 7	ILE A 29 LEU A 73 ILE A 81 ASP A 165	42A A 402 ( 4.7A) None None None	0.85A	1uwjA-4xrlA: 21.9	1uwjA-4xrlA: 27.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 12	ILE A 29 VAL A 37 ALA A 50 ILE A 82 LEU A 105 MET A 106 LEU A 154	42A A 402 ( 4.7A) None 42A A 402 (-3.2A) None 42A A 402 ( 4.9A) None 42A A 402 ( 4.9A)	0.61A	2y7jA-4xrlA: 28.1	2y7jA-4xrlA: 24.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 10	ILE A 29 VAL A 37 ALA A 50 ILE A 82 LEU A 105 MET A 106 LEU A 154	42A A 402 ( 4.7A) None 42A A 402 (-3.2A) None 42A A 402 ( 4.9A) None 42A A 402 ( 4.9A)	0.58A	2y7jB-4xrlA: 28.1	2y7jB-4xrlA: 24.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 10	ILE A 29 VAL A 37 ALA A 50 ILE A 82 LEU A 105 MET A 106 LEU A 154	42A A 402 ( 4.7A) None 42A A 402 (-3.2A) None 42A A 402 ( 4.9A) None 42A A 402 ( 4.9A)	0.61A	2y7jC-4xrlA: 28.1	2y7jC-4xrlA: 24.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 10	ILE A 29 VAL A 37 ALA A 50 ILE A 82 LEU A 105 MET A 106 LEU A 154	42A A 402 ( 4.7A) None 42A A 402 (-3.2A) None 42A A 402 ( 4.9A) None 42A A 402 ( 4.9A)	0.56A	2y7jD-4xrlA: 28.1	2y7jD-4xrlA: 24.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	6 / 12	VAL A 37 ALA A 50 GLU A 69 LEU A 73 ILE A 82 ILE A 138	None 42A A 402 (-3.2A) None None None None	1.08A	3gcsA-4xrlA: 35.6	3gcsA-4xrlA: 46.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 12	VAL A 37 ALA A 50 ILE A 82 ILE A 138 HIS A 145	None 42A A 402 (-3.2A) None None None	0.88A	3gcsA-4xrlA: 35.6	3gcsA-4xrlA: 46.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 12	VAL A 37 ALA A 50 LYS A 52 GLU A 69 LEU A 73 ILE A 82 ILE A 138	None 42A A 402 (-3.2A) 42A A 402 (-4.1A) None None None None	1.16A	3hegA-4xrlA: 36.9	3hegA-4xrlA: 48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 8	ALA A 50 LYS A 52 GLU A 69 LEU A 105 MET A 106	42A A 402 (-3.2A) 42A A 402 (-4.1A) None 42A A 402 ( 4.9A) None	0.89A	3lfaA-4xrlA: 36.4	3lfaA-4xrlA: 46.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 9	ILE A 29 ALA A 50 LYS A 52 MET A 106 LEU A 154	42A A 402 ( 4.7A) 42A A 402 (-3.2A) 42A A 402 (-4.1A) None 42A A 402 ( 4.9A)	0.58A	3miyB-4xrlA: 17.2	3miyB-4xrlA: 26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ASD_A_BAXA1500_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	4 / 6	ILE A 72 LEU A 154 ILE A 163 CYH A 164	None 42A A 402 ( 4.9A) None None	0.87A	4asdA-4xrlA: 20.9	4asdA-4xrlA: 25.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 12	ALA A 50 LYS A 52 LEU A 73 ILE A 101 HIS A 145 LEU A 154 ASP A 165	42A A 402 (-3.2A) 42A A 402 (-4.1A) None None None 42A A 402 ( 4.9A) None	0.96A	4c8bA-4xrlA: 22.1	4c8bA-4xrlA: 27.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	8 / 12	VAL A 37 ALA A 50 ILE A 82 ASP A 109 ASP A 147 LYS A 149 ASN A 152 LEU A 154	None 42A A 402 (-3.2A) None None None None None 42A A 402 ( 4.9A)	1.05A	4i41A-4xrlA: 25.1	4i41A-4xrlA: 25.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	4 / 7	ASP A 109 ASN A 152 LEU A 154 ASP A 165	None None 42A A 402 ( 4.9A) None	0.33A	4ogrE-4xrlA: 30.8	4ogrE-4xrlA: 33.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	6 / 12	ILE A 29 ALA A 50 GLU A 69 ILE A 101 LEU A 154 ASP A 165	42A A 402 ( 4.7A) 42A A 402 (-3.2A) None None 42A A 402 ( 4.9A) None	0.81A	4qmnA-4xrlA: 26.7	4qmnA-4xrlA: 27.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 10	ILE A 29 ALA A 50 ILE A 82 LEU A 105 LEU A 154	42A A 402 ( 4.7A) 42A A 402 (-3.2A) None 42A A 402 ( 4.9A) 42A A 402 ( 4.9A)	0.75A	4rz7A-4xrlA: 8.3	4rz7A-4xrlA: 16.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	7 / 12	ALA A 50 LYS A 52 LEU A 73 HIS A 145 LEU A 154 CYH A 164 ASP A 165	42A A 402 (-3.2A) 42A A 402 (-4.1A) None None 42A A 402 ( 4.9A) None None	0.99A	4u0iA-4xrlA: 21.3	4u0iA-4xrlA: 25.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XOY_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 6	ALA A 50 GLN A 103 LEU A 105 MET A 106 LEU A 154	42A A 402 (-3.2A) 42A A 402 (-3.9A) 42A A 402 ( 4.9A) None 42A A 402 ( 4.9A)	0.19A	4xoyA-4xrlA: 49.7	4xoyA-4xrlA: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XP3_A_DX4A401_0 (MITOGEN-ACTIVATED PROTEIN KINASE 1)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 6	ALA A 50 GLN A 103 LEU A 105 MET A 106 LEU A 154	42A A 402 (-3.2A) 42A A 402 (-3.9A) 42A A 402 ( 4.9A) None 42A A 402 ( 4.9A)	0.24A	4xp3A-4xrlA: 51.8	4xp3A-4xrlA: 99.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 9	ILE A 29 GLY A 30 VAL A 37 ALA A 50 MET A 106	42A A 402 ( 4.7A) None None 42A A 402 (-3.2A) None	0.73A	5lw1B-4xrlA: 36.9	5lw1B-4xrlA: 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 9	ILE A 29 VAL A 37 ALA A 50 ILE A 82 MET A 106	42A A 402 ( 4.7A) None 42A A 402 (-3.2A) None None	0.69A	5lw1B-4xrlA: 36.9	5lw1B-4xrlA: 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 10	GLY A 30 VAL A 37 ALA A 50 LEU A 105 MET A 106	None None 42A A 402 (-3.2A) 42A A 402 ( 4.9A) None	0.67A	5lw1E-4xrlA: 36.4	5lw1E-4xrlA: 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 10	VAL A 37 ALA A 50 ILE A 82 LEU A 105 MET A 106	None 42A A 402 (-3.2A) None 42A A 402 ( 4.9A) None	0.64A	5lw1E-4xrlA: 36.4	5lw1E-4xrlA: 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	5 / 9	GLY A 30 VAL A 37 ALA A 50 LEU A 105 MET A 106	None None 42A A 402 (-3.2A) 42A A 402 ( 4.9A) None	0.58A	5lw1H-4xrlA: 37.2	5lw1H-4xrlA: 10.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FNM_A_1N1A1001_1 (-)	4xrl	MITOGEN-ACTIVATED PROTEIN KINASE 1 (Rattus norvegicus)	8 / 12	ILE A 29 VAL A 37 ALA A 50 LYS A 52 GLU A 69 ILE A 101 MET A 106 LEU A 154	42A A 402 ( 4.7A) None 42A A 402 (-3.2A) 42A A 402 (-4.1A) None None None 42A A 402 ( 4.9A)	0.76A	6fnmA-4xrlA: 23.5	6fnmA-4xrlA: 27.40

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1UWH_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",4,"ILE A  29;VAL A  37;ILE A  81;ASP A 165","42A A 402 ( 4.7A);None;None;None","0.62A","1uwhA-4xrlA:22.3",null],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",4,"ILE A  29;LEU A  73;ILE A  81;ASP A 165","42A A 402 ( 4.7A);None;None;None","0.85A","1uwjA-4xrlA:21.9","1uwhA-4xrlA:27.91"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"ILE A  29;VAL A  37;ALA A  50;ILE A  82;LEU A 105;MET A 106;LEU A 154","42A A 402 ( 4.7A);None;42A A 402 (-3.2A);None;42A A 402 ( 4.9A);None;42A A 402 ( 4.9A)","0.61A","2y7jA-4xrlA:28.1","1uwjA-4xrlA:27.33"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"ILE A  29;VAL A  37;ALA A  50;ILE A  82;LEU A 105;MET A 106;LEU A 154","42A A 402 ( 4.7A);None;42A A 402 (-3.2A);None;42A A 402 ( 4.9A);None;42A A 402 ( 4.9A)","0.58A","2y7jB-4xrlA:28.1","2y7jA-4xrlA:24.57"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"ILE A  29;VAL A  37;ALA A  50;ILE A  82;LEU A 105;MET A 106;LEU A 154","42A A 402 ( 4.7A);None;42A A 402 (-3.2A);None;42A A 402 ( 4.9A);None;42A A 402 ( 4.9A)","0.61A","2y7jC-4xrlA:28.1","2y7jB-4xrlA:24.57"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"ILE A  29;VAL A  37;ALA A  50;ILE A  82;LEU A 105;MET A 106;LEU A 154","42A A 402 ( 4.7A);None;42A A 402 (-3.2A);None;42A A 402 ( 4.9A);None;42A A 402 ( 4.9A)","0.56A","2y7jD-4xrlA:28.1","2y7jC-4xrlA:24.57"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",6,"VAL A  37;ALA A  50;GLU A  69;LEU A  73;ILE A  82;ILE A 138","None;42A A 402 (-3.2A);None;None;None;None","1.08A","3gcsA-4xrlA:35.6","2y7jD-4xrlA:24.57"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"VAL A  37;ALA A  50;ILE A  82;ILE A 138;HIS A 145","None;42A A 402 (-3.2A);None;None;None","0.88A","3gcsA-4xrlA:35.6","3gcsA-4xrlA:46.41"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"VAL A  37;ALA A  50;LYS A  52;GLU A  69;LEU A  73;ILE A  82;ILE A 138","None;42A A 402 (-3.2A);42A A 402 (-4.1A);None;None;None;None","1.16A","3hegA-4xrlA:36.9","3gcsA-4xrlA:46.41"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ALA A  50;LYS A  52;GLU A  69;LEU A 105;MET A 106","42A A 402 (-3.2A);42A A 402 (-4.1A);None;42A A 402 ( 4.9A);None","0.89A","3lfaA-4xrlA:36.4","3hegA-4xrlA:48.15"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ILE A  29;ALA A  50;LYS A  52;MET A 106;LEU A 154","42A A 402 ( 4.7A);42A A 402 (-3.2A);42A A 402 (-4.1A);None;42A A 402 ( 4.9A)","0.58A","3miyB-4xrlA:17.2","3lfaA-4xrlA:46.96"],["4ASD_A_BAXA1500_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",4,"ILE A  72;LEU A 154;ILE A 163;CYH A 164","None;42A A 402 ( 4.9A);None;None","0.87A","4asdA-4xrlA:20.9","3miyB-4xrlA:26.96"],["4C8B_A_0LIA1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"ALA A  50;LYS A  52;LEU A  73;ILE A 101;HIS A 145;LEU A 154;ASP A 165","42A A 402 (-3.2A);42A A 402 (-4.1A);None;None;None;42A A 402 ( 4.9A);None","0.96A","4c8bA-4xrlA:22.1","4asdA-4xrlA:25.71"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",8,"VAL A  37;ALA A  50;ILE A  82;ASP A 109;ASP A 147;LYS A 149;ASN A 152;LEU A 154","None;42A A 402 (-3.2A);None;None;None;None;None;42A A 402 ( 4.9A)","1.05A","4i41A-4xrlA:25.1","4c8bA-4xrlA:27.32"],["4OGR_E_ADNE401_1","CYCLIN-DEPENDENT KINASE 9","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",4,"ASP A 109;ASN A 152;LEU A 154;ASP A 165","None;None;42A A 402 ( 4.9A);None","0.33A","4ogrE-4xrlA:30.8","4i41A-4xrlA:25.47"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",6,"ILE A  29;ALA A  50;GLU A  69;ILE A 101;LEU A 154;ASP A 165","42A A 402 ( 4.7A);42A A 402 (-3.2A);None;None;42A A 402 ( 4.9A);None","0.81A","4qmnA-4xrlA:26.7","4ogrE-4xrlA:33.06"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ILE A  29;ALA A  50;ILE A  82;LEU A 105;LEU A 154","42A A 402 ( 4.7A);42A A 402 (-3.2A);None;42A A 402 ( 4.9A);42A A 402 ( 4.9A)","0.75A","4rz7A-4xrlA:8.3","4qmnA-4xrlA:27.45"],["4U0I_A_0LIA1001_2","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",7,"ALA A  50;LYS A  52;LEU A  73;HIS A 145;LEU A 154;CYH A 164;ASP A 165","42A A 402 (-3.2A);42A A 402 (-4.1A);None;None;42A A 402 ( 4.9A);None;None","0.99A","4u0iA-4xrlA:21.3","4rz7A-4xrlA:16.19"],["4XOY_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ALA A  50;GLN A 103;LEU A 105;MET A 106;LEU A 154","42A A 402 (-3.2A);42A A 402 (-3.9A);42A A 402 ( 4.9A);None;42A A 402 ( 4.9A)","0.19A","4xoyA-4xrlA:49.7","4u0iA-4xrlA:25.39"],["4XP3_A_DX4A401_0","MITOGEN-ACTIVATED PROTEIN KINASE 1","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ALA A  50;GLN A 103;LEU A 105;MET A 106;LEU A 154","42A A 402 (-3.2A);42A A 402 (-3.9A);42A A 402 ( 4.9A);None;42A A 402 ( 4.9A)","0.24A","4xp3A-4xrlA:51.8","4xoyA-4xrlA:99.42"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ILE A  29;GLY A  30;VAL A  37;ALA A  50;MET A 106","42A A 402 ( 4.7A);None;None;42A A 402 (-3.2A);None","0.73A","5lw1B-4xrlA:36.9","4xp3A-4xrlA:99.42"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"ILE A  29;VAL A  37;ALA A  50;ILE A  82;MET A 106","42A A 402 ( 4.7A);None;42A A 402 (-3.2A);None;None","0.69A","5lw1B-4xrlA:36.9","5lw1B-4xrlA:10.94"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"GLY A  30;VAL A  37;ALA A  50;LEU A 105;MET A 106","None;None;42A A 402 (-3.2A);42A A 402 ( 4.9A);None","0.67A","5lw1E-4xrlA:36.4","5lw1B-4xrlA:10.94"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"VAL A  37;ALA A  50;ILE A  82;LEU A 105;MET A 106","None;42A A 402 (-3.2A);None;42A A 402 ( 4.9A);None","0.64A","5lw1E-4xrlA:36.4","5lw1E-4xrlA:10.94"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",5,"GLY A  30;VAL A  37;ALA A  50;LEU A 105;MET A 106","None;None;42A A 402 (-3.2A);42A A 402 ( 4.9A);None","0.58A","5lw1H-4xrlA:37.2","5lw1E-4xrlA:10.94"],["6FNM_A_1N1A1001_1","-","4xrl","MITOGEN-ACTIVATED PROTEIN KINASE 1","Rattus norvegicus",8,"ILE A  29;VAL A  37;ALA A  50;LYS A  52;GLU A  69;ILE A 101;MET A 106;LEU A 154","42A A 402 ( 4.7A);None;42A A 402 (-3.2A);42A A 402 (-4.1A);None;None;None;42A A 402 ( 4.9A)","0.76A","6fnmA-4xrlA:23.5","5lw1H-4xrlA:10.94"]]